Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group - Eichenauer, Dennis Alexander; Meißner, Julia (The lancet. Oncology, 2017)
Gesehen am 22.11.2018